Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,492.15 -9.50 -0.06%
S&P 500 1,878.37 2.98 0.16%
NASDAQ 4,143.86 16.90 0.41%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

Orion Oyj : Orion invites analysts and media to Financial Statement Release conference on Tuesday 5 February 2013



 Orion Oyj : Orion invites analysts and media to Financial Statement Release
                    conference on Tuesday 5 February 2013

ORION CORPORATION STOCK EXCHANGE RELEASE 22 JANUARY 2013 at 10.00 AM EET

Orion will publish its Financial Statement Release for 2012 on Tuesday, 5
February 2013 approximatelyat 12:00 Finnish time (EET). The release and
related presentation material in Finnish and in English will be available on
the Group's homepage at www.orion.fi/en/investors promptly after the
publishing.

  News conference for analysts and media on Tuesday 5 February 2013 at 13:30
  EET

A news conference for analysts and media will be held on Tuesday 5 February
2013 at 13:30 EET atHotel Kämp, address Pohjoisesplanadi 29, Helsinki.
President and CEO Timo Lappalainen will give a brief presentation in English
on the financial review.

  Live webcast and conference call

The event can be followed live as a webcast accessible at
http://qsb.webcast.fi/o/orion/orion_2013_0205_q4/

Questions can be asked also through conference call lines after the result
presentation.

The conference call ID is 927 747 and the phone numbers to participate the
conference are:
when calling from the United States +1 866 803 8344
when calling from other countries +44 (0)20 7162 0125

  News conference recordings

A recording of the event in English and a recording of the presentation by the
President and CEO in Finnish will be available on the Orion website later the
same day.

  Silent period

The silent period preceding the publication is ongoing and continues until the
disclosure.

Orion Corporation

Timo Lappalainen  Jari Karlson   
President and CEO CFO  

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. Pharmaceutical R&D focuses on central nervous
system drugs, oncology and critical care drugs, and Easyhaler^® pulmonary
drugs.

Orion's net sales in 2011 amounted to EUR 918 million and the company had
about 3,400 employees. Orion's A and B shares are listed on NASDAQ OMX
Helsinki.

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Orion Oyj via Thomson Reuters ONE
HUG#1672063
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement